Labiotech.eu

News and Trends 21 Jan 2020

German Biotech Raises €11M to Regenerate Liver Damage

Biotech company HepaRegeniX has raised a Series B round that will allow its first candidate drug for liver disease to enter clinical trials later this year. Based in Tübingen, Germany, HepaRegenix was founded in 2017 with a €9M Series A round. The same investors are now taking part in a Series B round […]

January 21, 2020 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Jan 2020

Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants

An international collaboration involving researchers in Europe, Asia, and North America has begun preparations for testing in humans a therapeutic gel that could replace the need for corneal transplants for the treatment of blindness. Corneal transplants are the most common treatment for blindness caused by corneal injury. However, donor shortages and high costs make it […]

January 20, 2020 - 2 minutesmins - By Jonathan Smith

Best in Biotech 20 Jan 2020

How Much Salary Can You Expect in a Biotech Job?

If you’re thinking of taking a job in biotech, you’re probably wondering how much you’ll be paid. Here’s what you can expect depending on how high in the ladder your new position is. Salary is undoubtedly an important factor when searching for a new job position, so it’s important to know what you can expect. […]

January 20, 2020 - 7 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 18 Jan 2020

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop a prototype instrument able to store and retrieve 1 terabyte of information in 24 hours. The Molecular Encoding Consortium, led by Robert Nicol at the Broad […]

January 18, 2020 - 3 minutesmins - By External Contributor

rhino northern white embryo conservation

News and Trends 17 Jan 2020

International Collaboration on Brink of Resurrecting Northern White Rhinos

An international collaboration called BioRescue has taken a step forward in bringing back the Northern White Rhino with the creation of three embryos, which it hopes to bring to term in a surrogate in the coming months. The BioRescue team, including researchers based at the Leibniz Institute for Zoo and Wildlife Research, Germany, extracted egg […]

January 17, 2020 - 3 minutesmins - By Jonathan Smith

Startup Scout 17 Jan 2020

This Biotech Is Developing a Pill to Rival Antibiotics in Vaginal Infections

Gedea Biotech is nestled in the historic city of Lund, Sweden. The company is developing a pill that could tackle recurrent bacterial vaginosis infections without harming the vaginal microbiome like current antibiotics do. Mission: To develop a pill that can clear bacterial vaginosis by restoring normal acidity levels in the vagina, which helps good bacteria […]

January 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 16 Jan 2020

Biotech Investment Firm Jeito Capital Launches with €200M Fund

The French investment firm Jeito Capital has launched this week with a €200M fund that will support up to 15 drug-development start-ups with a focus on European companies. Jeito Capital is the brainchild of Rafaèle Tordjman, whose background in medicine and research as well as investment in life sciences led her to setting up the […]

January 16, 2020 - 2 minutesmins - By External Contributor

News and Trends 16 Jan 2020

BioNTech Expands Cancer Portfolio With US Biotech Acquisition

German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal worth €60M, both to expand its cancer therapy pipeline and establish a US base. The deal is expected to complete in the second half of 2020, after which Neon will operate as a subsidiary of BioNTech. BioNTech has arguably scooped […]

January 16, 2020 - 2 minutesmins - By Helen Albert

News and Trends 15 Jan 2020

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese Astellas Pharma to complete phase I trials of candidate off-the-shelf T-cell therapies for cancer including CAR T-cell and TCR therapies. According to the deal, Adaptimmune will collaborate with Universal Cells, a subsidiary of Astellas. The partners will aim to identify […]

January 15, 2020 - 2 minutesmins - By Jonathan Smith

Expert Advice 15 Jan 2020

How to Spot a Biotech Winner: Investment Lessons from Sofinnova

Making one biotech a success is hard enough, but correctly predicting multiple winners is the bread and butter of Antoine Papiernik, Managing Partner of Sofinnova Partners, one of the biggest and most prosperous life science venture capital investors in Europe. Papiernik began his career in corporate finance. In 1995, he was working in investment in […]

January 15, 2020 - 10 minutesmins - By Helen Albert

News and Trends 14 Jan 2020

Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing

Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene editing technology it has licensed from researchers at Rutgers University in the US. After a year of research and development, the UK biotech has incorporated the base-editing technique into its drug discovery platform and will use it to develop better […]

January 14, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Jan 2020

Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany

The US company bluebird bio has launched the first gene therapy for the blood disorder transfusion-dependent beta thalassemia in the EU, with a hospital in Germany becoming its first qualified treatment center. Bluebird bio’s gene therapy, branded as Zynteglo, was given conditional market approval by the EU in June 2019. It was the first gene […]

January 14, 2020 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

German Biotech Raises €11M to Regenerate Liver Damage

Medical Gel Prepares to Enter Clinical Trials for Replacing Corneal Transplants

How Much Salary Can You Expect in a Biotech Job?

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

International Collaboration on Brink of Resurrecting Northern White Rhinos

This Biotech Is Developing a Pill to Rival Antibiotics in Vaginal Infections

Biotech Investment Firm Jeito Capital Launches with €200M Fund

BioNTech Expands Cancer Portfolio With US Biotech Acquisition

Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas

How to Spot a Biotech Winner: Investment Lessons from Sofinnova

Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing

Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!